Skip to content
DraconiticResearch
Search Sources API
190,869 studies31 sourcesUpdated 57 min ago
Peer-reviewedLicence not statedJAMA

Treatment With 9-mg Mazdutide for Weight Reduction in Chinese Adults With Obesity

  • Leili Gao1
  • H X Jiang2,3
  • Hanqing Cai4
  • Junhang Tian5
  • Bimin Shi6
  • Wei Qiu7
  • Chun‐Jui Huang8
  • Jie Han9,10
  • Zhang Suhe11
  • Shuguang Pang12
  • Yan Bi13
  • Lei Chen14
23 more authors
  • Xuejiang Gu15
  • Junfeng Han9,10
  • QINGYANG MA16
  • DENG Huan16
  • YANQI WANG16
  • LI LI16
  • Han Han‐Zhang16
  • LEI QIAN16
  • Linong Ji1
  • GLORY-2 Trial Investigators
  • Qiufang Lian17
  • Hua Li17
  • Yawei Zhang17
  • Lingchun Lv17
  • Haiyan Meng17
  • Long Wang17
  • Yuquan He17
  • Xiaohua Lü17
  • Tao Yang17
  • Xuqin Zheng17
  • Xihu Qin17
  • Tie Zhang17
  • Yuzhu Zhao17
17 affiliations
  1. 1Department of Endocrinology and Metabolism, Peking University People’s Hospital, Beijing, China
  2. 2First Affiliated Hospital and College of Clinical Medicine, State Key Laboratory of Light Superalloys, Henan University of Science and Technology, Luoyang, China
  3. 3State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing, China
  4. 4Department of Endocrinology, Second Norman Bethune Hospital of Jilin University, Changchun, China
  5. 5Department of Endocrinology, Luoyang Third People’s Hospital, Luoyang, China
  6. 6Department of Endocrinology, First Affiliated Hospital of Soochow University, Suzhou, China
  7. 7Department of Endocrinology, Huzhou Central Hospital, Huzhou, China
  8. 8Department of Endocrinology, People’s Hospital of Xuancheng, Xuancheng, China
  9. 9Department of Endocrinology and Metabolism, Tongji Hospital of Tongji University, Shanghai, China
  10. 10Department of Endocrinology, China National Petroleum Corporation Central Hospital, Langfang, China
  11. 11Department of Endocrinology, Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China
  12. 12Department of Endocrinology, Jinan Central Hospital, Jinan, China
  13. 13Department of Endocrinology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China
  14. 14Department of Endocrinology, Suzhou Municipal Hospital, Suzhou, China
  15. 15Department of Endocrinology, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
  16. 16Innovent Biologics Inc, Suzhou, China
  17. 17for the GLORY-2 Trial Investigators
Open at sourceDOICite

Related

  1. Diabetes attenuates weight reduction-mediated liver fibrosis regression in persons with morbid obesity.
    Daiki Matsubara, Yumie Takeshita, Masahiro Mori +9
    Journal of diabetes investigationPeer-reviewedCC BY-NCFull textEpidemiology & public healthEurope PMC
  2. Associations between the “Double Reduction” policy and physical activity and overweight/obesity among Chinese school-aged children: a quasi-experimental difference-in-differences analysis
    Wenhui Yu, Bing Zhang
    Frontiers in Public HealthPeer-reviewedCC BY 4.0Full textEpidemiology & public healthCrossrefEurope PMCPMC
  3. Advances in pharmacologic management of obesity: oral semaglutide for weight management
    Fnu Zainab, Abdul Haseeb Hasan
    Annals of medicine and surgery (2012)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Association of infant weight gain patterns with early childhood obesity among infants born small or large for gestational age
    Yu-Shan Chang, Tsung Yu
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textObstetrics, gynaecology & paediatricsCrossref
  5. Continuous glucose monitoring after discontinuation of incretin-based obesity pharmacotherapy: indirect evidence and a research framework for metabolic stability and weight maintenance
    Andrijana Koceva, Andrej Janez, Mojca Jensterle
    Frontiers in endocrinologyPeer-reviewedCC BYFull textEndocrinology & metabolismEurope PMC

Cite

BibTeXRIS
BibTeX
@article{gao2026treatment,
  title = {{Treatment With 9-mg Mazdutide for Weight Reduction in Chinese Adults With Obesity}},
  author = {Leili Gao and H X Jiang and Hanqing Cai and Junhang Tian and Bimin Shi and Wei Qiu and Chun‐Jui Huang and Jie Han and Zhang Suhe and Shuguang Pang and Yan Bi and Lei Chen and Xuejiang Gu and Junfeng Han and QINGYANG MA and DENG Huan and YANQI WANG and LI LI and Han Han‐Zhang and LEI QIAN and Linong Ji and GLORY-2 Trial Investigators and Qiufang Lian and Hua Li and Yawei Zhang and Lingchun Lv and Haiyan Meng and Long Wang and Yuquan He and Xiaohua Lü and Tao Yang and Xuqin Zheng and Xihu Qin and Tie Zhang and Yuzhu Zhao},
  journal = {JAMA},
  year = {2026},
  month = jun,
  doi = {10.1001/jama.2026.8142},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC13244275/},
}
RIS
TY  - JOUR
TI  - Treatment With 9-mg Mazdutide for Weight Reduction in Chinese Adults With Obesity
AU  - Leili Gao
AU  - H X Jiang
AU  - Hanqing Cai
AU  - Junhang Tian
AU  - Bimin Shi
AU  - Wei Qiu
AU  - Chun‐Jui Huang
AU  - Jie Han
AU  - Zhang Suhe
AU  - Shuguang Pang
AU  - Yan Bi
AU  - Lei Chen
AU  - Xuejiang Gu
AU  - Junfeng Han
AU  - QINGYANG MA
AU  - DENG Huan
AU  - YANQI WANG
AU  - LI LI
AU  - Han Han‐Zhang
AU  - LEI QIAN
AU  - Linong Ji
AU  - GLORY-2 Trial Investigators
AU  - Qiufang Lian
AU  - Hua Li
AU  - Yawei Zhang
AU  - Lingchun Lv
AU  - Haiyan Meng
AU  - Long Wang
AU  - Yuquan He
AU  - Xiaohua Lü
AU  - Tao Yang
AU  - Xuqin Zheng
AU  - Xihu Qin
AU  - Tie Zhang
AU  - Yuzhu Zhao
PY  - 2026
DA  - 2026/06/07
JO  - JAMA
DO  - 10.1001/jama.2026.8142
UR  - https://pmc.ncbi.nlm.nih.gov/articles/PMC13244275/
SN  - 0002-9955
SN  - 0098-7484
SN  - 1538-3598
SN  - 2376-8118
ER  -